When Cells at Work! hit theaters in Japan, nobody expected it to become one of the year’s biggest cultural surprises.

ABOUT 5.7 MILLION men could have an autoimmune disease, according to a 2024 study published in the Journal of Clinical Investigation. The authors believe it’s the first to estimate the prevalence of ...

Inflammation and tumorigenesis are intricately connected processes with significant overlap in their underlying mechanisms. Chronic inflammation is now ...

A new platform comprehensively profiles CAR T-cells during manufacturing, revealing phenotypic shifts. This allows for ...

The cure to cancer may not be hidden in some drug or chemical but within our own body. A team of Chinese researchers recently ...

Bats live long, cancer-free lives using extra tumor-fighting genes and stable immune systems. This may unlock new ways to ...

The late-breaking abstracts presented on the last day of the 2025 European Hematology Association (EHA) Congress show “what a vibrant clinical specialty we’re in,” according to session cochair Brian ...

The phase 1b trial’s primary endpoints are the occurrence of adverse events, including dose-limiting toxicities, and the ...

In modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets. Researchers ...

Once hailed as the future of immuno-oncology, it’s been a tough few months for any remaining fans of anti-TIGIT antibodies. | ...

Study findings suggest that SA-HFIRE causes a dynamic shift in tumor lymphatic and blood microvascular structures, ...

Knowable Magazine shares how studies show psychological strain can accelerate tumors and asks if beta blockers slow them down.